Botulinum Toxin: A Comprehensive Review of Its Molecular Architecture and Mechanistic Action.
Abstract
Botulinum toxin (BoNT), the most potent substance known to humans, likely evolved not to kill but to serve other biological purposes. While its use in cosmetic applications is well known, its medical utility has become increasingly significant due to the intricacies of its structure and function. The toxin's structural complexity enables it to target specific cellular processes with remarkable precision, making it an invaluable tool in both basic and applied biomedical research. BoNT's potency stems from its unique structural features, which include domains responsible for receptor recognition, membrane binding, internalization, and enzymatic cleavage. This division of labor within the toxin's structure allows it to specifically recognize and interact with synaptic proteins, leading to precise cleavage at targeted sites within neurons. The toxin's mechanism of action involves a multi-step process: recognition, binding, and catalysis, ultimately blocking neurotransmitter release by cleaving proteins like SNAP-25, VAMP, and syntaxin. This disruption in synaptic vesicle fusion causes paralysis, typically in peripheral neurons. However, emerging evidence suggests that BoNT also affects the central nervous system (CNS), influencing presynaptic functions and distant neuronal systems. The evolutionary history of BoNT reveals that its neurotoxic properties likely provided a selective advantage in certain ecological contexts. Interestingly, the very features that make BoNT a potent toxin also enable its therapeutic applications, offering precision in treating neurological disorders like dystonia, spasticity, and chronic pain. In this review, we highlight the toxin's structural, functional, and evolutionary aspects, explore its clinical uses, and identify key research gaps, such as BoNT's central effects and its long-term cellular impact. A clear understanding of these aspects could facilitate the representation of BoNT as a unique scientific paradigm for studying neuronal processes and developing targeted therapeutic strategies.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 시술 | botulinum toxin
|
보툴리눔독소 주사 | dict | 2 | |
| 해부 | cellular
|
scispacy | 1 | ||
| 해부 | membrane
|
scispacy | 1 | ||
| 해부 | synaptic
|
scispacy | 1 | ||
| 해부 | neurotransmitter
|
scispacy | 1 | ||
| 해부 | synaptic vesicle
|
scispacy | 1 | ||
| 해부 | peripheral neurons
|
scispacy | 1 | ||
| 해부 | central nervous system
|
scispacy | 1 | ||
| 해부 | CNS
→ central nervous system
|
scispacy | 1 | ||
| 해부 | neuronal
|
scispacy | 1 | ||
| 약물 | BoNT
→ Botulinum toxin
|
C0006055
Botulinum Toxins
|
scispacy | 1 | |
| 질환 | paralysis
|
C0522224
Paralysed
|
scispacy | 1 | |
| 질환 | neurotoxic
|
scispacy | 1 | ||
| 질환 | neurological disorders
|
C0027765
nervous system disorder
|
scispacy | 1 | |
| 질환 | dystonia
|
C0013421
Dystonia
|
scispacy | 1 | |
| 질환 | spasticity
|
C0026838
Muscle Spasticity
|
scispacy | 1 | |
| 질환 | chronic pain
|
C0150055
Chronic pain
|
scispacy | 1 | |
| 기타 | Botulinum Toxin: A
|
scispacy | 1 | ||
| 기타 | Its
|
scispacy | 1 | ||
| 기타 | humans
|
scispacy | 1 | ||
| 기타 | VAMP
|
scispacy | 1 | ||
| 기타 | syntaxin
|
scispacy | 1 | ||
| 기타 | BoNT
→ Botulinum toxin
|
scispacy | 1 |
MeSH Terms
Humans; Botulinum Toxins; Animals; Neurons
📑 인용 관계
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
관련 논문
- Local therapeutic strategies for neurocutaneous dysesthesia: from capsaicin to cannabinoids.
- Comparative efficacy of intralesional therapies for keloid scars: a network meta-analysis.
- Adverse neurological events following botulinum toxin type A: A case series of post-injection seizures and paralysis.
- Decreased utilization of component separation techniques over time in complex abdominal wall reconstruction following introduction of preoperative botulinum toxin A.
- Current Perspectives on Pectoralis Minor Syndrome: A Narrative Review.